We are live on
!
Find out more
HA
HHLR Advisors Portfolio holdings
AUM
$832M
Turnover
30.23%
1-Year Est. Return
32.38%
This Fund
S&P 500
This Quarter
Est. Return
+50.61%
1 Year Est. Return
+32.38%
3 Year Est. Return
+137.31%
5 Year Est. Return
+86.76%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$3.52B
(+47%)
Cap. Flow
+$396M
Cap. Flow
% of AUM
3.62%
Top 10 Holdings %
Top 10 Hldgs %
72.03%
Holding
77
New
17
Increased
11
Reduced
16
Closed
3
Avg Time Held
0.8
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$406M |
| 2 |
Zoom
ZM
|
+$119M |
| 3 |
argenx
ARGX
|
+$74.6M |
| 4 |
Pinduoduo
PDD
|
+$68.3M |
| 5 |
TSMC
TSM
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$207M |
| 2 |
VIE
Viela Bio, Inc. Common Stock
VIE
|
+$80.4M |
| 3 |
Align Technology
ALGN
|
+$62.2M |
| 4 |
Snap
SNAP
|
+$53.1M |
| 5 |
Sea Limited
SE
|
+$47.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.56% |
| 2 | Technology | 23.22% |
| 3 | Consumer Discretionary | 23.15% |
| 4 | Communication Services | 14.32% |
| 5 | Consumer Staples | 6.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RNAM
51
DELISTED
Avidity Biosciences
RNAM
| $12M | 0.11% |
+425,000
| New | +$12.3M |
2020 Q2
0 quarters
|
|
|
GRUB
52
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $11.9M | 0.11% |
84,693
| – | – |
2020 Q1
1 quarter
|
|
53
DELISTED
HOOKIPA Pharma
HOOK
| $11M | 0.1% |
94,325
| – | – |
2019 Q2
4 quarters
|
|
54
Burning Rock Biotech
BNR
$165M
| $10.8M | 0.1% |
+40,000
| New | +$11M |
2020 Q2
0 quarters
|
|
55
DELISTED
Merus
MRUS
| $9.65M | 0.09% |
600,000
| – | – |
2019 Q4
2 quarters
|
|
|
EIDX
56
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $8.51M | 0.08% |
178,600
| – | – |
2018 Q4
6 quarters
|
|
|
CALT
57
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $8.15M | 0.07% |
+350,000
| New | +$6.93M |
2020 Q2
0 quarters
|
|
58
Cypherpunk Technologies Inc
CYPH
$325M
| $7.53M | 0.07% |
+360,404
| New | +$7.73M |
2020 Q2
0 quarters
|
|
59
Sohu.com
SOHU
$329M
| $7.39M | 0.07% |
802,034
| – | – |
2018 Q4
6 quarters
|
|
60
Passage Bio
PASG
$11.6M
| $6.85M | 0.06% |
12,531
| – | – |
2020 Q1
1 quarter
|
|
61
10x Genomics
TXG
$9.43B
| $6.7M | 0.06% |
75,000
| – | – |
2019 Q3
3 quarters
|
|
62
Ridgetech Inc
RDGT
$3.01M
| $6.68M | 0.06% |
134
| – | – |
2019 Q3
3 quarters
|
|
63
Keurig Dr Pepper
KDP
$46.5B
| $6.01M | 0.05% |
+211,556
| New | +$5.74M |
2020 Q2
0 quarters
|
|
64
GDS Holdings
GDS
$5.07B
| $5.31M | 0.05% |
+66,700
| New | +$4.13M |
2020 Q2
0 quarters
|
|
|
TCRR
65
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $4.96M | 0.05% |
322,903
| – | – |
2019 Q3
3 quarters
|
|
66
Huazhu Hotels Group
HTHT
$14.5B
| $4.51M | 0.04% |
+128,786
| New | +$4.28M |
2020 Q2
0 quarters
|
|
67
Uxin Ltd
UXIN
$227M
| $4.29M | 0.04% |
29,965
-42,478
| -59% | -$6.35M |
2019 Q3
3 quarters
|
|
|
CBMG
68
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $3.52M | 0.03% |
235,214
| – | – |
2019 Q3
3 quarters
|
|
|
CVET
69
DELISTED
Covetrus, Inc. Common Stock
CVET
| $2.77M | 0.03% |
155,124
| – | – |
2020 Q1
1 quarter
|
|
70
Agora
API
$365M
| $1.33M | 0.01% |
+30,050
| New | +$1.42M |
2020 Q2
0 quarters
|
|
|
NEW
71
DELISTED
Puxin Limited American Depositary Shares, each representing twenty Ordinary Shares
NEW
| $651K | 0.01% |
12,615
| – | – |
2018 Q4
6 quarters
|
|
|
CIH
72
DELISTED
China Index Holdings Limited American Depository Shares
CIH
| $642K | 0.01% |
300,000
| – | – |
2019 Q2
4 quarters
|
|
73
Mereo BioPharma
MREO
$49.4M
| $382K | ﹤0.01% |
+124,970
| New | +$220K |
2020 Q2
0 quarters
|
|
|
SFUN
74
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
| $340K | ﹤0.01% |
30,000
| – | – |
2018 Q4
6 quarters
|
|
75
NVIDIA
NVDA
$5.25T
| – | – |
-2,000,000
| Closed | -$13.2M | – |
|
Similar funds
ACGDR
NCM
SIG
AFA
BEC
AFA
AWA
GWS
HHLR Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, HHLR Advisors held 77 positions worth $10.9B, up 47% from $7.42B the previous quarter. Its ten largest holdings account for 72% of the portfolio.
HHLR Advisors deployed $396M of net new capital in Q2 2020, opening 17 new positions and adding to 11 existing holdings. Its largest new stake was TSMC: 1,100,495 shares worth $62.5M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was JD.com, an estimated $207M trimmed.
- HHLR Advisors's largest Q2 2020 buy was TSMC: 1,100,495 shares worth $62.5M.
- HHLR Advisors added most to Alibaba in Q2 2020, an estimated $406M increase.
- HHLR Advisors's biggest Q2 2020 reduction was JD.com, cutting an estimated $207M.
- HHLR Advisors fully exited Snap in Q2 2020, selling an estimated $53.1M.
- HHLR Advisors's ten largest holdings make up 72% of its $10.9B portfolio in Q2 2020.
- HHLR Advisors opened 17 new positions and closed 3 in Q2 2020.
- HHLR Advisors's portfolio value rose 47% quarter-over-quarter to $10.9B.
Based on HHLR Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.